General Medicine and Primary Care - Global Neurology Academy

1-16 of 108

Rethinking Migraine Prevention: Where CGRP-Targeting Therapies Fit
Rethinking Migraine Prevention: Where CGRP-Targeting Therapies Fit
NeuroFrontiers
Rethinking Migraine Prevention: Where CGRP-Targeting Therapies Fit
Alexandria May, PharmD, BCPS; Nina Riggins, MD
- Alexandria May, PharmD, BCPS
- Nina Riggins, MD
Treating ADHD in the Presence of Comorbidities
Treating ADHD in the Presence of Comorbidities
NeuroFrontiers
Treating ADHD in the Presence of Comorbidities
Roberto Olivardia, PhD
- Roberto Olivardia, PhD
Sleep and ADHD: Breaking the Cycle
Sleep and ADHD: Breaking the Cycle
NeuroFrontiers
Sleep and ADHD: Breaking the Cycle
Roberto Olivardia, PhD
- Roberto Olivardia, PhD
Tracking ADHD Over Time in the MTA Study
Tracking ADHD Over Time in the MTA Study
NeuroFrontiers
Tracking ADHD Over Time in the MTA Study
James Swanson, PhD
- James Swanson, PhD
Supporting Students with ADHD and Learning Differences
Supporting Students with ADHD and Learning Differences
NeuroFrontiers
Supporting Students with ADHD and Learning Differences
Roberto Olivardia, PhD
- Roberto Olivardia, PhD
Untangling ADHD and Co-Occurring Conditions
Untangling ADHD and Co-Occurring Conditions
NeuroFrontiers
Untangling ADHD and Co-Occurring Conditions
Roberto Olivardia, PhD
- Roberto Olivardia, PhD
Long-Term ADHD Treatment: Examining Stimulant Tolerance
Long-Term ADHD Treatment: Examining Stimulant Tolerance
NeuroFrontiers
Long-Term ADHD Treatment: Examining Stimulant Tolerance
James Swanson, PhD
- James Swanson, PhD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CE
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Alireza Atri, MD, PhD; Raymond Scott Turner, MD, PhD
0.50 credits
- Alireza Atri, MD, PhD
- Raymond Scott Turner, MD, PhD
- Dani Cabral, MD
0.50 credits
Insights on Migraine Care Disparities from OVERCOME
Insights on Migraine Care Disparities from OVERCOME
AudioAbstracts
Insights on Migraine Care Disparities from OVERCOME
Ryan Quigley
- Ryan Quigley
Improving Migraine Diagnosis in Vulnerable Populations
Improving Migraine Diagnosis in Vulnerable Populations
NeuroFrontiers
Improving Migraine Diagnosis in Vulnerable Populations
Juliana VanderPluym, MD
- Juliana VanderPluym, MD
Measuring Migraine: The Potential of CGRP
Measuring Migraine: The Potential of CGRP
NeuroFrontiers
Measuring Migraine: The Potential of CGRP
Shradha Kakde, MBBS
- Shradha Kakde, MBBS
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
NeuroFrontiers
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
Rethinking Vestibular Migraine in Clinical Practice
Rethinking Vestibular Migraine in Clinical Practice
NeuroFrontiers
Rethinking Vestibular Migraine in Clinical Practice
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
NeuroFrontiers
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
Juliana VanderPluym, MD
- Juliana VanderPluym, MD
The Role of CGRPs in First-Line Preventive Migraine Therapy
The Role of CGRPs in First-Line Preventive Migraine Therapy
NeuroFrontiers
The Role of CGRPs in First-Line Preventive Migraine Therapy
Charles Turck, PharmD, BCPS, BCCCP; Richard B. Lipton, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Richard B. Lipton, MD
- Hope O'Brien, MD, MBA, FAHS, FAAN
How Real-World Adherence Is Shaping Preventive Migraine Treatment
How Real-World Adherence Is Shaping Preventive Migraine Treatment
NeuroFrontiers
How Real-World Adherence Is Shaping Preventive Migraine Treatment
Alexandria May, PharmD, BCPS; Jessica Ailani, MD, FAHS, FAAN, FANA
- Alexandria May, PharmD, BCPS
- Jessica Ailani, MD, FAHS, FAAN, FANA

Prev
1
2
3
…
6
7
Next

1/6